Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monkhorst

Showing results (81-90 of 160) with videos related to

Pageof 16
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 17, 2018
Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural MesotheliomaJosine Quispel-Janssen, Vincent van der Noort, Jeltje F de Vries, et al.
Lung Cancer (Amsterdam, Netherlands)|June 25, 2026
Enrichment of SMARCA4 mutations in lung carcinomas presenting as cancer of unknown primaryTobias Martinot, Lydia H N Schonewille, Dina Ruano, et al.
The Oncologist|December 9, 2020
Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic CancerEmilie M J van Brummelen, Sanne Huijberts, Carla van Herpen, et al.
ESMO Open|June 12, 2025
The role of whole-genome sequencing for guiding systemic therapy in patients with soft tissue sarcomaP van der Laan, W J van Houdt, H van Boven, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2022
Tobacco Smoking-Related Mutational Signatures in Classifying Smoking-Associated and Nonsmoking-Associated NSCLCSophie M Ernst, Joanne M Mankor, Job van Riet, et al.
JCO Precision Oncology|October 11, 2021
Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non-Small-Cell Lung CancerRobert D Schouten, Daan C L Vessies, Linda J W Bosch, et al.
ERJ Open Research|March 29, 2019
Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisionsKarlijn Hummelink, Mirte Muller, Theodora C Linders, et al.
Molecular Oncology|June 8, 2022
Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II-IIIA NSCLC patientsDaan C L Vessies, Milou M F Schuurbiers, Vincent van der Noort, et al.
Lung Cancer (Amsterdam, Netherlands)|December 10, 2024
The DETECTION project part 1: An international Delphi survey about diagnostics and treatment of anterior mediastinal cystic lesionsFlorit Marcuse, Daphne Dumoulin, Koen Hartemink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 13, 2023
A Dysfunctional T-cell Gene Signature for Predicting Nonresponse to PD-1 Blockade in Non-small Cell Lung Cancer That Is Suitable for Routine Clinical DiagnosticsKarlijn Hummelink, Renaud Tissier, Linda J W Bosch, et al.
Pageof 16

Showing results (81-90 of 160) with videos related to

Sort By:
Pageof 16
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 17, 2018
Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural MesotheliomaJosine Quispel-Janssen, Vincent van der Noort, Jeltje F de Vries, et al.
Lung Cancer (Amsterdam, Netherlands)|June 25, 2026
Enrichment of SMARCA4 mutations in lung carcinomas presenting as cancer of unknown primaryTobias Martinot, Lydia H N Schonewille, Dina Ruano, et al.
The Oncologist|December 9, 2020
Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic CancerEmilie M J van Brummelen, Sanne Huijberts, Carla van Herpen, et al.
ESMO Open|June 12, 2025
The role of whole-genome sequencing for guiding systemic therapy in patients with soft tissue sarcomaP van der Laan, W J van Houdt, H van Boven, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2022
Tobacco Smoking-Related Mutational Signatures in Classifying Smoking-Associated and Nonsmoking-Associated NSCLCSophie M Ernst, Joanne M Mankor, Job van Riet, et al.
JCO Precision Oncology|October 11, 2021
Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non-Small-Cell Lung CancerRobert D Schouten, Daan C L Vessies, Linda J W Bosch, et al.
ERJ Open Research|March 29, 2019
Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisionsKarlijn Hummelink, Mirte Muller, Theodora C Linders, et al.
Molecular Oncology|June 8, 2022
Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II-IIIA NSCLC patientsDaan C L Vessies, Milou M F Schuurbiers, Vincent van der Noort, et al.
Lung Cancer (Amsterdam, Netherlands)|December 10, 2024
The DETECTION project part 1: An international Delphi survey about diagnostics and treatment of anterior mediastinal cystic lesionsFlorit Marcuse, Daphne Dumoulin, Koen Hartemink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 13, 2023
A Dysfunctional T-cell Gene Signature for Predicting Nonresponse to PD-1 Blockade in Non-small Cell Lung Cancer That Is Suitable for Routine Clinical DiagnosticsKarlijn Hummelink, Renaud Tissier, Linda J W Bosch, et al.
Pageof 16